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In this study, the diagnostic and predictive value of brainstem, 
middle latency, and cortical auditory evoked responses (BMC- 
1 AERs) obtained in the neonatal period in 81 preterm infants was 
j assessed in relation to neurodevelopmental outcome. The pre- 
I term infants were neonatally classified according to risk category 
and gestational age. The BMC-AERs were analyzed with respect 
j to detectability, latencies, and amplitudes as well as derived 
latency and amplitude measures. At 5 y of age the neurodevel­
opmental outcome was assessed from neurologic and neuropsy­
chologic evaluations. The results showed that BMC-AER differ­
ences mainly correlated with risk category (low risk/high risk) 
and to some extent with degree of prematurity. In view of these 
I findings the degree of prematurity and the eflect of risk category 
have to be taken into account, when BMC-AERs are applied in 
the preterm period to predict neurodevelopmental outcome. In 
this study the BMC-AERs for infants with abnormal neurode­
velopmental outcome were scarcely distinguishable from the 
} BMC-AERs for infants with normal neurodevelopmental out- 
i come. Thus far, this and previous reports have indicated that
BMC-AERs in preterm infants are useful in maturational studies 
and with infants showing symptoms related to lesions or dys­
function of the peripheral and/or central auditory system. For 
predicting neurodevelopmental outcome in preterm infants, 
BMC-AERs are of limited clinical value. (Pediatr Res 42: 
670-677, 1997)
Abbreviations 
ABR, auditory brainstem evoked response 
ACR, auditory cortical evoked response 
BMC-AER, brainstem, middle latency and cortical auditory 
evoked response 
CA, conceptional age 
GA, gestational age 
IPL, interpeak latency
MLR, auditory middle latency evoked response 
NNI, neonatal neurologic inventory 
PPA, peak-to-peak amplitude
The relatively high short-term and long-term morbidity in 
preterm infants has encouraged many authors to focus on the 
determination of neonatal risk factors to improve the prediction 
of neurodevelopmental outcome (1-3). Several neonatal risk 
factors and risk scores have been proposed as predictors of 
neurodevelopmental outcome in preterm infants and/or infants 
with low birth weight (3, 4). However, these neonatal risk 
factors and risk scores are of limited clinical value, because a 
considerable number preterm infants predicted to be at low risk 
develop neurodevelopmental impairments during infancy or 
childhood.
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Brainstem (ABR), middle latency (MLR), and cortical 
(ACR) auditory evoked responses (BMC-AERs) primarily re­
flect the function of the peripheral and central auditory path­
ways. To a certain extent the BMC-AERs also give informa­
tion on the integrity of adjacent parts of the CNS. Several 
experiments have demonstrated selective vulnerability of au­
ditory relay nuclei in the preterm period, especially between 28 
and 40 wk GA (5, 6). In the past 15 y several authors have 
reported on the clinical importance of ABRs in newborn 
infants. Most of these studies have focused primarily on term 
infants, in particular on term infants with asphyxia or hyper­
bilirubinemia and on term infants at risk for hearing loss (7-9). 
Neonatal ABR abnormalities have been described in infants 
with perinatal complications (10-12). Some authors have 
stated that early physiologic indices can be used to predict 
long-term developmental trends (13). Some studies have con­
centrated on the predictive value of ABRs in relation to
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neurodevelopmental outcome or later language skills in term 
infants (13, 14). Only few authors have reported on ABR 
findings related to neurodevelopmental outcome in preterm 
infants (15—17). Majnemer et a l  (14) found evidence for the 
usefulness of the ABR as a diagnostic test for high risk 
neonates. Cox et al. (15) put forward that early ABR may 
predict long-term neurobehavioral development in low birth 
weight infants. Salamy and Eldredge (16) reported that infants 
with neurologic signs or demonstrable brain anomalies were 
four to five times more likely to exhibit deviant ABRs, They 
also reported that the synergistic effects of selected predictor 
variables further increased the risk associated with abnormal 
ABRs. On the other hand, Beverly et a l  (17) found that neither 
flash VERs nor ABRs provide a good prognostic indicator for 
neurodevelopmental outcome. Only a few reports have focused 
on the predictive value of the MLR and ACR for n euro devel­
op mental outcome in newborn infants (18). To our knowledge, 
BMC-AER abnormalities are not evaluated as a neonatal risk 
factor in preterm infants.
In the present study the diagnostic and predictive value of 
BMC-AERs obtained in preterm infants in the neonatal period 
is assessed in relation to the long-term neurodevelopmental 
outcome. First, we studied the differences in (cumulative) 
detectability of the various BMC-AER components obtained in 
the preterm period between low risk and high risk preterm 
infants, early and late preterm infants, and infants with and 
without a normal neurologic outcome at 5-7 y of age. We also 
studied the influence of the degree of prematurity on BMC- 
AERs obtained at 29-32-wk CA and at 33-35-wk CA, for 
early low risk infants and early high risk infants with neuro- 
logic/neuropsychologic abnormalities at age 5-7 y. Further­
more, we analyzed the BMC-AER differences at 33-35-wk CA 
between early and late low risk preterm infants and between 
low risk preterm infants with normal and abnormal neurologic/ 
neuropsychologic outcome at age 5-7 y. Finally, the individual 
BMC-AER results for infants with an abnormal neurodevelop­
mental outcome at age 5-7 y were analyzed. This study has 
been approved by the Ethics Committee of the University 
Hospital Nijmegen. Informed consent was obtained from all 
parents o f infants in this study.
METHODS
Patients. Eighty-one randomly selected preterm infants (GA 
25-34 wk) were included in this prospective study, This group 
consisted of inborn and outborn infants who were admitted to 
the Neonatal Intensive Care Unit of the University Hospital 
Nijmegen between 1983 and 1985. Infants with dysgenetic 
brain lesions, major congenital anomalies, or well defined 
clinical syndromes were excluded from the study.
In the neonatal period the infants were classified as high risk 
or low risk according to the semiquantitative NNI. The NNI 
assessment was performed in the first 2 wk after birth. The NNI 
is based on four items: 1) clinical neurologic examination, 2) 
echoencephalography, 3) arterial or capillary blood pH, and 4) 
Apgar score. Based on the NNI, 65 of the 81 preterm infants 
were classified as low risk and 16 as high risk (i.e. having one 
or more of the four NNI high risk criteria). Five of the 65 low
risk infants and seven of the 16 high risk infants died in the 
neonatal period. Forty-four of the surviving low risk infants 
(73%), and all of the nine surviving high risk infants (100%) 
had a complete follow-up. The other infants were not available 
to follow-up because of migration or withdrawal by the par­
ents. The patient characteristics and methods to assess long­
term neurodevelopmental outcome are reported in a companion 
study (2).
BMC-AER recordings. BMC-AERs were obtained every 2 
wk during the preterm period, at 40-wk CA, 52-wk CA, and at 
5-7 y of age using a Nicolet CA 1000 or Nicolet Pathfinder. 
Stimulation parameters and other technical data are given in 
Table 1 (19-21). Based on previous studies performed by our 
research group we have selected those BMC-AER parameters 
that were determined to be of clinical relevance in preterm 
infants (22-24). These parameters were: the latencies and 
amplitudes of ipsilateral ABR components I, II, III, and V, 
IPLs III-I, V-III, V-I, IPL ratio V-IH/III-I, and amplitude ratio 
V/I. For the the contralateral derivation these ABR parameters 
were: latencies and amplitudes of contralateral ABR compo­
nents lie and Vc and IPL Vc-IIc. For the MLR latencies and 
amplitudes of components P0 and Na, IPL Na-PO and PPA 
PO-Na were analyzed. The latencies and amplitudes of ACR 
components Na, PbPl, P2p (p = preterm wave form), N2p, 
IPL N2p-P2p, and PPA P2p-N2p were also analyzed, but at
33-35 wk only the latencies Na and N2p were considered. 
Detectability of individual BMC-AER components was deter­
mined for infants with registrations obtained both during 30-
34-wk CA and 3 5 -4 1-wk CA. The last registration during 
30-34-wk CA and the first registration during 3 5 -4 1-wk CA 
were considered. Differences in detectability (30-34-wk CA) 
or cumulative detectability (30-34- and/or 3 5 -4 1-wk CA) of 
BMC-AER components between several subgroups were stud­
ied. At the age of 5-7 y, a follow-up investigation was per­
formed consisting of a neurophysiologic, neurologic, and neu- 
ropsychologic evaluation.
Based on the NNI and the neurologic evaluation at 5-7 y of 
age, four subgroups were determined: 1) low risk infants 
without major neurologic abnormalities, 2) low risk infants 
with major neurologic abnormalities, 3) high risk infants with-
Table 1. BMC-AER test parameters
Parameter ABR MLR ACR
Intensity (dB) 70 70 70
Rate (Hz) 11.1 4.7 Mean 0.5
Mode (rarefaction) Regular Regular Random
Binaural/monaural Monaural Monaural Binaural
High pass filter (Hz) 30 5 1
Low pass filter (Hz) 3000 250 30
Contralateral masking + — —
Channels 2 4 4
Time base (ms) 20 100 1000
Prestimulus time (ms) 5 25 250
Sample points 512 256 256
Derivations Cz-A2 Cz-(A2A1) Cz-A2
Cz-Al C4'-C3' Cz-Al
C4'-(A2A1) C4'-A2
C3'-(A2A1) C3'-A1
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out major neurologic abnormalities, 4) high risk infants with 
major neurologic abnormalities. Based on the NNI and the 
neuropsychologic evaluation at 5-7 y of age, four analogous 
subgroups were determined.
Statistics. The statistical analyses for examining differences 
between low risk and high risk preterm infants, between early 
(25-30-wk GA) and late (31-34-wk GA) preterm infants and 
between normal and abnormal neurologic, respectively, neu­
ropsychologic outcome at 5-7 y, for the (cumulative) detect­
ability of the various BMC-AER components, were performed 
using Fisher’s exact test for 2 X 2 tables. Before performing 
further statistical tests, the distributions of the different BMC- 
AER parameters were studied. Although sometimes relatively 
large values of skewness occurred, no important deviations 
from Gaussian distributions could be established. In those 
cases with the largest values of skewness we performed, next 
to the t tests, also nonparametric tests (Kruskal-Wallis test). No 
differences between these two methods were found. Because of 
uniformity with respect to the statistical approach, only the 
results according to the t tests are presented. The BMC-AER 
differences between the group of early low risk infants and 
early high risk infants with neurologic or neuropsychologic 
abnormalities at age 5-7 y were analyzed for the recordings at 
30 wk (or 29-31 wk) and 34 wk (or 33-35 wk) for averaged 
left-right observations (including incomplete observations) 
with two-sample t tests. To analyze the BMC-AER differences 
at 34-wk CA (33-35-wk CA) between early and late low risk 
preterm infants and between normal and abnormal neurologic 
or neuropsychologic outcomes, two-way analyses of variance 
were used for averaged left-right observations (including in­
complete observations).
Any difference was considered to be statistically significant 
if ap  value ^  0.05 was found. In case 0.05 <  p  ^  0.10 it was 
said that a trend to differences could be shown. The individual 
BMC-AER results were assessed using reference values ob­
tained by the authors (19-22). The statistical analyses were 
earned out using the SAS statistical package (25).
RESULTS
Detectability o f  BMC-AER components. Table 2 shows the 
absence of the complete BMC-AER recording in the preterm 
infants with a normal long-term neuro development, and in the 
preterm infants with an abnormal long-term neurodevelop­
ment. No important differences with respect to the presence or 
absence of the complete ABR, MLR, or ACR were found. The 
majority of the absent ABR, MLR, or ACR recordings were, as 
could be expected, obtained between 25- and 30-wk CA.
The effect of risk category was assessed by analyzing the 
differences in (cumulative) detectability between the low risk 
and high risk subgroups, irrespective of outcome or degree of 
prematurity (Table 3). The detectability at 30-34-wk CA for 
ABR components I, III, and Vc, MLR component Na and ACR 
component Na was significantly higher in the low risk sub­
group than in the high risk subgroup for at least one stimulation 
side and/or derivation. For MLR component Pa and for ACR 
component P2p the detectability was significantly lower in the 
low risk subgroup than in the high risk subgroup for one 
stimulation side and/or derivation. For the cumulative detect­
ability the differences between the high risk and low risk 
subgroup were smaller than for the detectability at 30-34-wk 
CA. Generally, the results for detectability and cumulative 
detectability pointed in the same direction. Because no large 
differences in (cumulative) detectability between left-sided 
stimulation and right-sided stimulation (ABR and MLR) and 
different derivations/electrodes (ACR) were found, we give 
only the significant differences or trends to differences after 
left-sided stimulation, with respect to left derivation.
The effect of prematurity on the detectability of BMC-AER 
components was studied by analyzing the differences in (cu­
mulative) detectability between early low risk and late low risk 
preterm groups with a normal neurologic outcome. The size of 
the other early and late subgroups did not permit analogous 
analyses. For the ABR and ACR no clear differences were 
found between these subgroups. The detectability of MLR 
component Pa was significantly lower in the early low risk 
subgroup with a normal outcome after left-sided stimulation 
for two derivations.
The relation between the detectability of BMC-AER com­
ponents and the long-term outcome was determined by ana­
lyzing the differences in (cumulative) detectability between the 
neurologically normal and the neurologically abnormal late 
low risk group. For ACR component P2p a significantly higher 
cumulative detectability was found for the left lateral deriva­
tion in neurologically normal infants. The size of the other 
subgroups did not permit analogous analyses.
BMC-AER differences related to neonatal risk category. 
The significant differences or trends to differences for BMC- 
AERs obtained at 29-31-wk CA and 33-35-wk CA between 
early low risk infants and early high risk infants with neuro­
logic or neuropsychologic abnormalities at 5-7 y of age are 
given in Table 4, A an B.
For abnormal neurologic outcomes, the mean ABR latencies 
I and Vc, ABR IPL Vc-Hc, MLR latency P0, and ACR 
latencies Na (lateral derivation) and P2p (central derivation)
T ab le  2. Absence o f  the complete ABR, MLR, and ACR in (low risk and high risk) preterm infants
Response
Normal outcome Abnormal outcome
Absent responses obtained between Absent responses obtained between
25-34-wk CA 25-30-wk CAf 25-34-wk CA 25-30-wk CAt
ABR 33 7 (21%) 7/7 20 3 (15%) 2/3
MLR 33 5 (15%) 4/5 20 3 (15%) 2/3
ACR 33 5(15%) 2 IS 20 2(10%) 0/2
* Total number of infants/recordings.
t  Number of absent responses obtained between 25-30-wk CA/number of absent responses obtained between 25- and 34-wk CA.
T ab le  3. Effect o f  risk category on detectability o f  ABR, MLR, and A C R  components irrespective o f  outcome and prematurity
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Detectability rate Cumulative detectability rate
30-34-wk CA 30-34- and/or 3 5 -4 1-wk CA
Response Low risk High risk p value Low risk High risk p value
ABR (n = 31) {n = 9) (n «  31) (» = 9)
I 1 0.78 0.05 --- --- ---
III 0.94 0.56 0.02m 1 0.67 0.009
lie 0.94 0.67 0.07 1 0.78 0.05
Vc 0.97 0.67 0.03 1 0.78 0.05
MLR {ii = 30) (n = 9) {n = 30) (» -  9)
Pa* 0.33 0.75 0.05 --- --- ---
ACR (» = 31) (n = 9) in =  31) (« = 9)
Naf 0.74/0.65 0.22/0.25 0.008/0.06 0.87/— 0.56/— 0.06/—
(n = 24) (« = 9) (ii = 24) (n =  9)
P2pi 0.33 0.78 0,05 --- --- ---
ABR and MLR after left-sided stimulation and ACR for left lateral derivation. Only significant (p <  0.05) or trends to differences (0.05 <  p ^ 0.10) are given.
* Derivation Cu-A1A2.
t  Derivation Cz-Al, C3-A1, respectively.
$ Derivation Cz~A2.
Table 4. Effect o f  risk category on BMC-AERs
A. Differences between early low-risk and high-risk infants with neurological abnormalities at 5-7 years according to two sample Student’s t-tests
Response Derivation 29-31-wk CA p value 33-35-wk CA p value
ABR n = 3/rt = 4 n = 3 In ~  5
Latency I (ms) Ipsi lateral Early low risk <  early high risk 2 --- --- ---
Latency Vc (ms) Ipsi lateral Early low risk <  early high risk 4 --- ---
IPL V-III (ms) Ipsilateral --- --- Early low risk <  early high risk 3
IPL Vc-IIc (ms) Ipsilateral Early low risk <  early high risk 4 Early low risk <  early high risk 6
Amplitude ratio V/I Ipsilateral Early low risk >  early high risk 6 — —
IPL ratio V-ni/m-I Ipsilateral --- --- Early low risk <  early high risk 4
MLR • n — 41 n =  3 n ~  3 In = 5
Latency PO (ms) Central, ipsilateral Early low risk <  early high risk 0.003 Early low risk <  early high risk <0.001
PPA PO-Na (jxV) Contralateral, Early low risk >  early high risk 0.02-0.08 --- --- ---
ipsilateral
ACR
mlicoII
Latency Na (ms) Central, lateral Early low risk <  early high risk 0.05-0.10 -— ---
Latency P2p (ms) Central, lateral Early low risk <  early high risk 0.03-0.09 --- --- ---
PPA P2p-N2p (/xV) Lateral Early low risk >  early high risk 0.07 -— --- ---
B. Significant differences or trends to difference between early low risk and high risk infants with neuropsychologic abnormalities at 5-7 y according to
two sample t tests are given
ABR n = 5/n = 3 n = 4 in =  3
Latency I (ms) Ipsilateral Early low risk <  early high risk 2 --- ---
Latency III (ms) Ipsilateral --- --- Early low risk <  early high risk 8
Latency V (ms) Ipsilateral Early low risk <  early high risk 6 Early low risk <  early high risk 6
Latency He (ms) Ipsilateral --- --- Early low risk <  early high risk 5
Latency Vc (ms) Ipsilateral Early low risk <  early high risk 4 Early low risk <  early high risk 6
IPL V-HI (ms) Ipsilateral Early low risk <  early high risk 7 --- ---
IPL Vc-IIc (ms) Contralateral Early low risk <  early high risk 2 --- ----
MLR n -  5 hi — 3
m11ii
Latency PO (ms) Central, ipsi- and Early low risk <  early high risk 0.007 Early low risk <  early high risk 0.004
contralateral
IPL Na-PO (ms) Central, ipsi- and --- --- Early low risk >  early high risk 0.04(
contralateral
ACR n = 3 hi = 3
Latency Na (ms) Central Early low risk <  early high risk 0.04 --- ---
Latency P2p (ms) Central Early low risk <  early high risk 0.08 --- ---
obtained between 29- and 31-wk CA were significantly longer 
in the early high risk infants than in the early low risk infants. 
For the contralateral derivation the PPA of PON a was signif­
icantly lower in high risk infants. For abnormal neuropsycho­
logic outcomes, the same holds for ABR latencies I and Vc,
and ABR IPL Vc-IIc, MLR latency PO, and ACR latency Na 
(central derivation).
At 33-35-wk CA, for abnormal neurologic outcomes, sig­
nificant differences were found between early high risk and low 
risk infants with respect to ABR IPL V-III, ABR IPL ratio
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V-III/III-I, and MLR latency PO, with higher means in the early 
high risk infants. For abnormal neuropsychologic outcomes, 
significant differences were found for ABR latencies lie and 
MLR latency PO, in which early high risk infants also showed 
higher means than early low risk infants. The MLR IPL Na-PO 
was significantly lower in early high risk infants.
Relation between outcome, degree of prematurity and 
BMC-AER measures. In a two-way analysis of variance, the 
effect GA on the BMC-AERs obtained between 33- and 35-wk 
CA, as well as the effect of outcome on these BMC-AERs in 
low risk infants was evaluated. Generally, the means of the 
BMC-AER variables of the four subgroups were similar. Av­
eraged over neurologically normal and abnormal, the mean 
MLR PPA Na-PO (contralateral) was significantly higher for 
late preterm infants. Averaged over early and late the mean 
ACR Na latency was significantly higher in neuropsychologi- 
cally abnormal infants. In general, the estimated effects of GA 
were of the same magnitude as the effects of neurodevelop- 
mental outcome. In Table 5 the significant differences or trends 
to differences are given.
Individual BMC-AERs and abnormal neurodevelopmental 
outcome„ The individual BMC-AER results of high risk and 
low risk infants with neurologic and/or neuropsychologic ab­
normalities at 5-7 y of age are tabulated in Table 6 (high risk 
infants) and Table 7 (low risk infants). Applying our references 
values, five of the eight surviving high risk infants (63%) and 
two of 12 low risk infants (17%) showed an abnormal ABR 
(19-21). The abnormalities consisted of the absence of all 
components (three high risk infants), one or more components 
(one low risk infant) or increased (inter-peak) latencies (two 
high risk infants and one low risk infant). One low risk infant 
showed the absence of ABR components lie and Vc at 27-wk 
CA. However, at this CA level the absence of these compo­
nents cannot be considered as abnormal. Three surviving high
risk (38%) and nine low risk (75%) infants with an abnormal 
outcome had normal ABRs at the first recording.
For the MLR, six of eight surviving high risk infants (75%) 
and none of 12  low risk infants (0%) with an abnormal 
neurodevelopmental outcome had abnormal MLR responses. 
None of the surviving high risk (0%) and 10 of the low risk 
(83%) infants had a normal MLR. At this CA level the absence 
of one or more MLR components in two surviving high risk 
and two low risk infants cannot be considered as abnormal. 
The second follow-up MLR registration in these infants 
showed MLR abnormalities in one of the two surviving high 
risk infants and none of the two low risk infants.
For the ACR, four of the eight surviving high risk infants 
(50%) and one of the 12 low risk infants (8%) showed an 
abnormal ACR response. One of the surviving high risk (13%) 
and none of the low risk (0%) infants showed a normal ACR. 
Because of the CA level at time of registration the ACRs of 
three of the surviving high risk (38%) and 11 of the low risk 
(92%) infants cannot be considered as abnormal. We also 
analyzed the AERs of the high risk preterm infants who died in 
the neonatal period. Two of the seven infants (29%) showed 
ABR abnormalities, one infant (14%) had a normal ABR and 
four infants (57%) had one or more absent ABR components, 
but because of the CA-level at the time of registration this does 
not necessarily imply abnormality. The same holds for the 
MLR and the ACR.
DISCUSSION
Changes in BMC-AERs can be related to normal and ab­
normal functional and/or structural alterations of the auditory 
system. In preterm infants BMC-AERs reflect the functional 
and structural maturation of the auditory system. The appear­
ance of BMC-AERs in preterm infants bom between 25- and
Table 5. Low risk preterm infants classified by prematurity and neurologic outcome at 5 y: only significant differences
differences at 33-35-wk  CA are given according to two-way analyses of variance
or trend to
Response Derivation
Neurologic outcome (and prematurity) two-way
analyses of variance p value
ABR
IPL III-I (ms) Ipsi lateral Normal outcome <  abnormal outcome 0.08
IPL V-I (ms) Ipsilateral Normal early low risk >  normal late low risk 0.07
Abnormal early low risk <  abnormal late low risk*
Amplitude ratio V/I Ipsilateral Early low risk >  late low risk 0.053
MLR
IPL Na-PO (ms) Contralateral Normal outcome <  abnormal outcome 0.08
PPA PO-Na (jltV) Central, ipsilatal, contralateral Early low risk preterm <  late low risk preterm 0.05-
0.06
Neuropsychologic outcome (and prematurity) two-way
analyses of variance
MLR
Latency PO (ms) Contralateral, central Abnormal early low risk <  abnormal late low risk 0.08
ipsilateral, contralateral Normal early low risk >  normal late low risk 0.03-
Abnormal early low risk <  abnormal late low risk* 0.06
PPA PO-Na (/itV) Central Normal early low risk <  normal late low risk 0.08
Abnormal early low risk >  abnormal late low risk*
ACR
Latency Na (ms) Central Normal outcome <  abnormal outcome 0.008-
Lateral 0.04
* Significant interaction between early/late low risk preterm and normal/abnormal outcome.
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Table 6. Individual BMC-AER results obtained in high risk preterm infants with neurologic and/or neuropsychologic abnormalities at age
5 -7  y: also the results of the high risk preterm infants who died in the neonatal period are given*
Neurologic/
neuropsychologic
(ab)normal
Recording 
(wk CA) ABR MLR ACR
Deceased infants 
1 + /+ 26 It, Illf, V t, Hct, and V et absent POt, Nat absent Nat, PbP lt, P2pt and N2pt absent
2 + /+ 26 It, IHt, V t, n e t, and V et absent POt, Nat absent Nat, PbPlt, P2pt and N2pt absent
3 + /+ 28 It, m t ,  V t, Hct, and V et absent POt, Nat absent N at, N2pt absent
4 + /+ 26 It, m t ,  v t ,  n e t ,  and V et absent POf, Nat absent Nat, N2pf absent
5 + /+ 29 V-I, V-III and Vc-IIc increased Normal Normal
6 +/■f* 31 Normal PO increased Na increased
7 H-/+ 31 n it ,  n e t,  and Vc absent POt, Na absent Na increased, PbPlt, P2pt, N2pt absent
Surviving infants 
1 + /— 33 Normal Na and PO-Na increased N at absent
2 + /+ 29 I, Ult, V, n e t ,  and Vc absent POf, Naf absent Normal
3 + /+ 29 I, m t, V, n e t ,  and Vc absent POf absent P2pt absent
4 H-/+ 32 Normal PO increased PbPl increased, P2pt absent
5 H-/+ 31 V, Vc, V-I, and Vc-Hc increased PO increased Na increased
6 _l“/-|_ 31 Vc-IIc increased PO increased N at absent, P2p increased
7 + /+ 33 I, Hit, V, Hct, and Vc absent POt, Na absent Nat, PbPlt, P2pt and N2pt absent
8 - / + 33 Normal PO increased N at absent, PbPl increased
* The results are compared with the available normative data lo r each CA level.
t  At this specific postconceptional age the absence of this component cannot be considered as abnormal.
Table 7. Individual BMC-AER results obtained in low risk preterm infants with neurologic and/or neuropsychologic abnormalities at
age 5 -7  y*
Neurologic/
neuropsychologic Recording
Infant (ab)normal (wk CA) ABR MLR ACR
1 27 Ilct and V et absent POt, Nat absent Nat, PbP lt, P2pt, and N2pt absent
2 _l_ j _|_ 30 Normal Normal Nat and N2pt absent
3 _ /+ 30 Vc-IIc increased Normal Nat, PbP lt, P2pt, and N2pf absent
4 _j_/_j_ 31 Normal POt absent P2pt and N2pt absent
5 + / “ 32 Ilc t and Vc absent Normal P2p increased, N2pt absent
6 + /+ 30 Normal Normal N2pt absent
7 + / - 30 Normal Normal P bP lt and N2pt absent
8 — /+ 36 Normal Normal N2pf absent
9 + /+ 32 Normal Normal Nat, P2pt> and N2pt absent
10 — /+ 36 Normal Normal P2pt, N2pt absent
11 - / + 34 Normal Normal P2pt, N2pt absent
12 34 Normal Normal Nat, P2pt, and N2pt absent
* The results were compared with the available normative data for each CA level, 
t  At this specific postconceptional age the absence of this component cannot be considered as abnormal.
29-wk CA implies a certain degree of maturation of the 
auditory system (19-21, 26). Myelination of the auditory 
pathway is considered to be a requisite for function of the 
auditory system. Indeed, several studies have shown that my­
elination of the cochlear nerve and auditory structures in the 
brainstem starts between 26 and 29 wk CA or even as early as 
24 wk CA (21-29). For the majority, the myelination of the 
auditory brainstem pathways is completed between 40 and 44 
wk CA (28, 29). Other factors besides myelination, such as 
increasing synaptic efficiency, dendritic growth, and the sum­
mation, synchronization, and phase-locking capabilities of the 
auditory system, are also important in determining the central 
auditory conduction (28, 30, 31). The functional maturation of 
the auditory pathway is reflected by the changes in detectability, 
latencies, and amplitudes of BMC-AER components (19-21).
Prematurity predisposes infants to a variety of neurodevel- 
opmental and educational sequelae (15). The early identifica­
tion of infants who will exhibit long-term neurodevelopmental
abnormalities is difficult, and there are frequent false-negative 
results, Le> a substantial number of infants classified as low risk 
will show neurodevelopmental impairments in infancy or 
childhood. Several neuropathologic studies have demonstrated 
that, in the preterm period, in particular auditory structures in 
the brainstem, such as the cochlear nuclei, superior olivary 
complexes, and inferior colliculi, are vulnerable to perinatal 
anoxic-ischemic insults. Some authors have suggested that 
ABRs may predict long-term neurobehavioral development in 
preterm and low birth weight infants (14-18). However, BMC- 
AER measures are not thoroughly evaluated as neonatal risk 
factors (5, 6).
To determine whether BMC-AERs in high risk infants differ 
from those obtained in low risk infants, we compared the 
BMC-AER results of high risk and low risk subgroups. For 
both detectability and cumulative detectability differences were 
found between low risk and high risk infants for ABR, MLR, 
and ACR, Generally, the high risk group showed lower (cu­
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mulative) detectability rates than the low risk group. Differ­
ences between low risk and high risk infants were found also 
for BMC-AER latencies, IPLs, and amplitude measures (PPA 
and amplitude ratio). Because the size of some groups was too 
small, the comparison between low and high risk infants could 
be analyzed only for the early preterm infants with an abnormal 
neurologic/neuropsychologic outcome. In general, the laten­
cies and IPLs were longer and the PPAs were smaller in early 
high risk infants than in early low risk infants. The individual 
recordings showed also more ABR abnormalities in high risk 
preterm infants than in low risk infants. Much the same holds 
for the analysis of the individual MLR and ACR recordings. 
These longer latencies, longer IPLs, and lower PPAs can be the 
result of de/dysmyelination or delayed myelination and synap­
tic evolution of the central auditory pathway (28, 30, 31). 
Because the BMC-AER differences were generally more clear 
for recordings obtained at 29~31-wk CA than for recordings 
obtained at 33-35-wk CAS a delayed myelination seems more 
likely than a de/dysmyelination (23, 24).
In a previous report we have shown that the detectability of 
BMC-AER components increase during the neonatal period 
(22). Generally, in the preterm period we found no clear 
differences in (cumulative) detectability with respect to the 
degree of prematurity and neurologic/neuropsychologic out­
come. Previously we also reported that preterm birth affects the 
maturation of BMC-AERs, even in preterm infants with a 
normal neurodevelopmental outcome at 5 y of age (23, 24). 
Therefore, the degree of prematurity has to be taken into 
account when the relation between BMC-AERs and neurode­
velopmental outcome in preterm infants is studied. A complex 
pattern of BMC-AER differences was found between the var­
ious preterm subgroups (related to outcome and taking the 
degree of prematurity into account). The differences consisted 
not only of longer mean latencies and IPLs for early and 
abnormal low-risk infants, but concerning some BMC-AER 
measures also of shorter means. Based on the individual BMC- 
AER recordings of the preterm infants, no clear distinction 
could be made between preterm infants with and preterm 
infants without an abnormal neurodevelopmental outcome. 
This complex pattern of (generally small) BMC-AER differ­
ences might be due, in part, to potentially counteracting (patho) 
physiologic effects on the maturation of BMC-AERs. Whereas, 
delayed myelination results in longer latencies and IPLs and 
lower PPAs, other mechanisms, such as a disturbed synaptic 
efficacy or reduced dendritic growth, may result in less com­
plex auditory relay centres and, accordingly, to shorter laten­
cies and IPLs. Some of these counteracting effects might be 
related to prematurity alone, whereas others might be related to 
pathophysiologic mechanisms or combinations of prematurity 
and pathophysiologic mechanisms. These opposing effects 
might result in smaller BMC-AER differences than expected,
*
masking functional and/or structural changes in the auditory 
system.
This study shows that neonatally obtained BMC-AERs in 
preterm infants are influenced by risk category (high risk/low 
risk) as well as degree of prematurity, and that BMC-AERs are, 
to some extent, also related to neurodevelopmental outcome. 
However, the effect of risk category is more clear than the
effect of the degree of prematurity, or the effect related to 
neurodevelopmental outcome. These results imply that low 
risk preterm infants with a later abnormal neurodevelopmental 
outcome are barely detectable in the neonatal period using 
BMC-AERs. Because delayed myelination is likely to be an 
important factor in the BMC-AER differences found between 
low risk and high risk infants, prenatally emerging cerebral 
lesions may account for these differences. Recently, Burke and 
Tannenberg (32) reported that placental infarctions are associ­
ated with prenatal cerebral ischemic lesions. These prenatal 
cerebral ischemic lesions consist primarily of periventricular 
white matter lesions. These white matter lesions might be 
associated with disturbed myelination and result in transient 
BMC-AER abnormalities. Furthermore, it has been suggested 
that the maturation of the ABR can be faster in growth-retarded 
newborn infants than in appropriately growing infants. It has 
been postulated that the faster maturation might be related to 
raised levels of steroid hormones and catecholamines caused 
by placental dysfunction. It is known that steroid hormones and 
catecholamines have a variety of effects on neural maturation
(33).
From the present study we conclude that neonatally obtained 
BMC-AERs in preterm infants cannot be used to generate a 
simple neonatal risk factor, because there is no strong relation­
ship between BMC-AERs obtained in low risk preterm infants, 
and later neurodevelopmental outcome. These results, how­
ever, do not preclude the use of BMC-AERs as an additional 
indicator of risk, to strengthen the validity and/or predictive 
value of (current) neonatal risk scores. Furthermore, BMC- 
AERs obtained in preterm infants can be useful in maturational 
studies, in preterm infants at risk for heating disorders, and in 
infants clinically suspected of central (or peripheral) dysfunc­
tion of the auditory system.
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